Cite
YTHDF2 interference suppresses the EMT of cervical cancer cells and enhances cisplatin chemosensitivity by regulating AXIN1.
MLA
Wu, Min, et al. “YTHDF2 Interference Suppresses the EMT of Cervical Cancer Cells and Enhances Cisplatin Chemosensitivity by Regulating AXIN1.” Drug Development Research, vol. 83, no. 5, Aug. 2022, pp. 1190–200. EBSCOhost, https://doi.org/10.1002/ddr.21942.
APA
Wu, M., Chen, G., Liao, X., Xiao, L., & Zheng, J. (2022). YTHDF2 interference suppresses the EMT of cervical cancer cells and enhances cisplatin chemosensitivity by regulating AXIN1. Drug Development Research, 83(5), 1190–1200. https://doi.org/10.1002/ddr.21942
Chicago
Wu, Min, Guozhong Chen, Xiaowen Liao, Lihua Xiao, and Jianqing Zheng. 2022. “YTHDF2 Interference Suppresses the EMT of Cervical Cancer Cells and Enhances Cisplatin Chemosensitivity by Regulating AXIN1.” Drug Development Research 83 (5): 1190–1200. doi:10.1002/ddr.21942.